Your session is about to expire
← Back to Search
Betadine + Chlorhexidine for Broken Arm and Surgical Site Infection
Phase 4
Recruiting
Led By Mark Seeley, MD
Research Sponsored by Mark Seeley
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
Study Summary
This trial is investigating whether providers are doing a thorough enough job cleaning patients' fingernails before surgery.
Eligible Conditions
- Broken Arm
- Surgical Site Infection
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Type and number of organisms found in culture
Trial Design
2Treatment groups
Active Control
Group I: Betadine prepActive Control1 Intervention
Betadine prep prior to their operation
Group II: Chlorhexidine prepActive Control1 Intervention
Chlorhexidine prep prior to their operation
Find a Location
Who is running the clinical trial?
Mark SeeleyLead Sponsor
Mark Seeley, MD5.011 ReviewsPrincipal Investigator - Geisinger Clinic
Geisinger Clinic
5Patient Review
Dr. Seeley was excellent with my son when he broke his arm. My son needed surgery and Dr. Seeley was very understanding and explained everything perfectly. My son's arm is healed now and he is doing great! I would highly recommend Dr. Seeley to anyone, especially if you have kids!
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a known disorder that weakens your immune system.
Research Study Groups:
This trial has the following groups:- Group 1: Betadine prep
- Group 2: Chlorhexidine prep
Awards:
This trial has 5 awards, including:- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger